2m 2m 2m 2m 2m 2m 2m
PRIME MEDICINE (PRME)
NASDAQ
$2.94+$0.02 (+0.51%)
Price as of Aug 03, 2026 4:25 AM EDT- $527.4MMarket Cap
- -27.72%1-Year Change
- BiotechnologyIndustry
PRIME MEDICINE (PRME)
$2.94+$0.02 (+0.51%)
PRME | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.92 | ||
Change | -$0.10 (-3.31%) | ||
Open | $3.03 | ||
High | $3.04 | ||
Low | $2.91 | ||
Previous Close | $3.02 | ||
Volume | 1,836,827 | ||
30-Day Average Volume | 3,797,781 | ||
1-Week Change | -1.02% | ||
1-Month Change | -20.87% | ||
1-Year Change | -27.72% | ||
3-Year Change | -80.62% | ||
5-Year Change | -85.57% | ||
Fundamentals | |||
Shares Outstanding | 180.6M | ||
Total Assets | $294.7M | ||
Market Cap | $527.4M | ||
Enterprise Value | $463.3M | ||
Period: QTR TTM FY | |||
Revenue | $856,000.00 | ||
Net Income | -$49.1M | ||
Free Cash Flow | -$42.9M | ||
EBIT | -$49.1M | ||
EBITDA | -$47.3M | ||
Net Working Capital | $101.6M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | 541 | ||
P/B | 7 | ||
P/E | -10 | ||
PEG | 2 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/10/2019 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue